Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teruhiko Yokoyama

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Acta Medica Okayama|October 26, 2019
Comparison of Two Different Drugs for Overactive Bladder, Solifenacin and Mirabegron: A Prospective Randomized Crossover StudyMiyabi Inoue, Teruhiko Yokoyama
Lower Urinary Tract Symptoms|December 15, 2015
Statin-Associated Underactive BladderTeruhiko Yokoyama, Michael B Chancellor
Neurourology and Urodynamics|October 10, 2007
Correlation of urinary nerve growth factor level with pathogenesis of overactive bladderTeruhiko Yokoyama, Hiromi Kumon, Atsushi Nagai
Acta Medica Okayama|May 26, 2004
Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleepingTohru Araki, Teruhiko Yokoyama, Hiromi Kumon
Acta Medica Okayama|January 6, 2009
A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturiaTohru Araki, Teruhiko Yokoyama, Motoo Araki, et al.
Acta Medica Okayama|October 9, 2004
High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatmentsTeruhiko Yokoyama, Masaya Tsugawa, Atsushi Nagai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled studyTeruhiko Yokoyama, Hiromi Kumon, Yoshitsugu Nasu, et al.
The Journal of Urology|October 9, 2003
Calcineurin mediates bladder smooth muscle hypertrophy after bladder outlet obstructionKunihiro Nozaki, Kazuhito Tomizawa, Teruhiko Yokoyama, et al.
Acta Medica Okayama|August 25, 2012
Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxinTeruhiko Yokoyama, Yumiko Yamamoto, Tomonori Suzuki, et al.
Urologia Internationalis|April 7, 2005
Preliminary results of the effect of extracorporeal magnetic stimulation on urinary incontinence after radical prostatectomy: a pilot studyTeruhiko Yokoyama, Miyabi Inoue, Osamu Fujita, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Acta Medica Okayama|October 26, 2019
Comparison of Two Different Drugs for Overactive Bladder, Solifenacin and Mirabegron: A Prospective Randomized Crossover StudyMiyabi Inoue, Teruhiko Yokoyama
Lower Urinary Tract Symptoms|December 15, 2015
Statin-Associated Underactive BladderTeruhiko Yokoyama, Michael B Chancellor
Neurourology and Urodynamics|October 10, 2007
Correlation of urinary nerve growth factor level with pathogenesis of overactive bladderTeruhiko Yokoyama, Hiromi Kumon, Atsushi Nagai
Acta Medica Okayama|May 26, 2004
Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: a prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleepingTohru Araki, Teruhiko Yokoyama, Hiromi Kumon
Acta Medica Okayama|January 6, 2009
A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturiaTohru Araki, Teruhiko Yokoyama, Motoo Araki, et al.
Acta Medica Okayama|October 9, 2004
High-energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia: comparative study between 30-and 60-minute single treatmentsTeruhiko Yokoyama, Masaya Tsugawa, Atsushi Nagai, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 3, 2006
Comparison of 25 and 75 mg/day naftopidil for lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective, randomized controlled studyTeruhiko Yokoyama, Hiromi Kumon, Yoshitsugu Nasu, et al.
The Journal of Urology|October 9, 2003
Calcineurin mediates bladder smooth muscle hypertrophy after bladder outlet obstructionKunihiro Nozaki, Kazuhito Tomizawa, Teruhiko Yokoyama, et al.
Acta Medica Okayama|August 25, 2012
Intraprostatic botulinum neurotoxin type a injection for benign prostatic hyperplasia: preliminary results with a newly purified neurotoxinTeruhiko Yokoyama, Yumiko Yamamoto, Tomonori Suzuki, et al.
Urologia Internationalis|April 7, 2005
Preliminary results of the effect of extracorporeal magnetic stimulation on urinary incontinence after radical prostatectomy: a pilot studyTeruhiko Yokoyama, Miyabi Inoue, Osamu Fujita, et al.
Pageof 5